Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 410-419

  Guidal Giroux, Christine ^a   Gérard, Bénédicte ^b   Cavé, Hélène ^a   Duval, Michel ^a   Rohrlich, Pierre ^a   Elion, Jacques ^a   Vilmer, Etienne ^a   Grandchamp, Bernard ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

Author keywords

9p21; Acute lymphoblastic leukaemia; Deletion; Mapping; MTS1

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHROMOSOME; CLINICAL ARTICLE; FEMALE; GENE MAPPING; GENOTYPE; HUMAN; INFANT; MALE; MONONUCLEAR CELL; MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOUTHERN BLOTTING; T LYMPHOCYTE;

EID: 0030031325     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1497.x     Document Type: Article

References (28)

1. Cairns, P., Mao, L., Merlo, A., Lee, D.J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J.E. & Sidransky, D. (1994) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-417.
2. Caldas, C., Hahn, S.A., Dacosta, L.T., Redston, M.S., Schutte, M., Seymour, A.B., Weinstein, C.L., Hruban, R.H., Yeo, C.J. & Kern, S.E. (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genetics, 8, 410
3. INK4A) deletion in primary tumor cells of 163 leukemic patients. Blood, 85, 854
4. Diaz, M.O., Ziemin, S., Le Beau, M.M., Pitha, P., Smith, S.D., Chilcote, R.R. & Rowley, J.D. (1988) Homozygous deletion of the alpha and beta1-interferon genes in human leukemia and derived cell lines. Proceedings of the National Academy of Sciences of the United States of America, 85, 5259-5263.
5. Duro, D., Flexor, M.A., Bernard, O., Dagay, M.F., Berger, R. & Larsen, C.J. (1994) Alterations of the putative tumor suppressor gene p16/MTS1 in human hematological malignancies. Complex Rendus de l'Academie des Sciences, Serie III: Sciences de la Vie, 317, 913-919.
6. Grandchamp, B., deVerneuil, H., Beaumont, C., Chrétien, S., Walter, O. & Nordmann, Y. (1987) Tissue-specific expression of porphobilinogen deaminase: two isoenzymes from a single gene. European Journal of Biochemistry, 162, 105-110.
7. Hannon, G.J. & Beach, D. (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature, 371, 257-261.
8. INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84, 4038-4044.
9. Hussussian, C.J., Struewing, J.P., Goldstein, A.M., Higgins, P.A.T., Ally, U.S., Sheahan, M.D., Clark, W.H.J., Tucker, M.A. & Dracopoli, N.C. (1994) Germline p16 mutations in familial melanoma. Nature Genetics, 8, 15-21.
10. Johansson, B., Mertens, F. & Mitelman, F. (1993) Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes. Chromosomes and Cancer, 8, 205-218.
11. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day, R.S., Johnson, B.E. & Skolnick, M.H. (1994a) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
12. Kamb, A., Shattuckeidens, D., Eeles, R., Liu, Q., Gruis, N.A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaverfeldhaus, J., Mcclure, M., Aitken, J.F., Anderson, D.E., Bergman, W., Frants, R., Goldgar, D.E., Green, A., Maclennan, R., Martin, N.G., Meyer, L.J., Youl, P., Zone, J.J., Skolnick, M.H. & Cannonalbright, L.A. (1994b) Analysis of the P16 gene (CDKN2) as a candidate for the chromosome 9P melanoma susceptibility locus. Nature Genetics, 8, 22-26.
13. Liu, Q., Neuhausen, S., McClure, M., Frye, C., Weaverfeldhaus, J., Gruis, N.A., Eddington, K., Allalunisturner, M.J., Skolnick, M.H., Fujimura, F.K. & Kamb, A. (1995) CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene, 10, 1061-1067.
14. INK4A transcript. Cancer Research, 55, 2995-2997.
15. Middleton, P.G., Prince, R.A., Williamson, I.K., Taylor, P.R.A., Reid, M.M., Jackson, G.H., Katz, F., Chessells, J.M. & Proctor, S.J. (1991) Alpha interferon gene deletions in adults, children and infants with acute lymphoblastic leukemia. Leukemia, 5, 680.
16. Nobori, T., Miura, K., Wu, D.J., Lois, A., Takabayashi, K. & Carson, D.A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
17. Ogawa, S., Hirano, N., Sato, N., Takahashi, T., Hangaishi, A., Tanaka, K., Kurokawa, M., Tanaka, T., Mitani, K., Yazaki, Y. & Hirai, H. (1994) Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood, 84, 2431-2435.
18. Okuda, T., Shurtleff, S.A., Valentine, M.B., Raimondi, S.C., Head, D.R., Behm, F., Curcio-Brint, A.M., Liu, S., Pui, C.H., Sherr, C.J., Beach, D., Look, A.T. & Downing, J.R. (1995) Frequent deletion of p16INK4a/MTS1 and p15ink4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 85, 2321-2331.
19. Otsuki, T., Clark, H.M., Wellmann, A., Jaffe, K.S. & Raffeld, M. (1995) Involvement of CDKN2 (P16(INK4A)/MTS1) and P15(INK4B)/ MTS2 in human leukemias and lymphomas. Cancer Research, 55, 1436-1440.
20. Porcher, C., Malinge, M.C., Picat, C. & Grandchamp, B. (1992) A simplified method for determination of specific DNA or RNA copy number using quantitative PCR and an automatic DNA sequencer. BioTechniques, 13, 106-113.
21. Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J., Bauters, F., Wattel, E. & Fenaux, P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85, 657-663.
22. Raimondi, S.C. (1993) Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood, 81, 2237-2251.
23. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory. New York.
24. Serrano, M., Hannon, G.J. & Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/ CDK4. Nature, 366, 436-440.
25. Sill, H., Goldman, J.M. & Cross, N.C.P. (1995) Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood, 85, 2013-2016.
26. Stranks, G., Height, S.E., Mitchell, P., Jadayel, D., Yuille, M.A.R., Delord, C., Clutterbuck, R.D., Treleaven, J.G., Powles, R.L., Nacheva, E., Oscier, D.G., Karpas, A., Lenoir, G.M., Smith, S.D., Millar, J.L., Catovsky, D. & Dyer, M.J.S. (1995) Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood, 85, 893-901.
27. Tycko, B. & Sklar, J. (1990) Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells, 2, 1.
28. Zhou, X.L., Tarmin, L., Yin, J., Jiang, H.Y., Suzuki, H., Rhyu, M.G., Abraham, J.M. & Meltzer, S.J. (1994) The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene, 9, 3737-3741.